| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| JNJ16259685 |
|
409345-29-5 |
詳細(xì)
|
| PDK1 inhibitor2 |
|
850717-64-5 |
詳細(xì)
|
| SAR245409 |
|
934493-76-2 |
詳細(xì)
|
| PF4447943 |
|
1082744-20-4 |
詳細(xì)
|
| JNJ-42041935 |
|
1193383-09-3 |
詳細(xì)
|
| Nemorubicin |
奈莫柔比星;柰莫柔比星 |
108852-90-0 |
詳細(xì)
|
| Zileuton |
齊留通 |
111406-87-2 |
詳細(xì)
|
| IN00076730 |
|
1454700-89-0 |
詳細(xì)
|
| 5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-amine |
CEP-32496中間體 |
1188911-74-1 |
詳細(xì)
|
| Pitolisant hydrochloride |
|
903576-44-3 |
詳細(xì)
|
| LHW090-A7 |
|
1308256-94-1 |
詳細(xì)
|
| EGF816 mesylate |
|
1508250-72-3 |
詳細(xì)
|
| RG2833 |
|
1215493-56-3 |
詳細(xì)
|
| Mutant IDH1 inhibitor |
|
1429180-08-4 |
詳細(xì)
|
| Maytansinoid dM4 |
|
799840-96-3 |
詳細(xì)
|
| 3-(3-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
依魯替尼雜質(zhì)1（間位） |
1092788-11-8 |
詳細(xì)
|
| MI-503 |
|
1857417-13-0 |
詳細(xì)
|
| Avitinib |
艾維替尼 |
1557267-42-1 |
詳細(xì)
|
| SKF38393 |
|
67287-49-4 |
詳細(xì)
|
| N1-(2,4-Dimethoxybenzyl)-N2-(2-(pyridin-2-YL)ethyl)oxalamide |
N1-2,4-二甲氧基芐基-N2-2-吡啶基乙基草酰胺 |
745047-53-4 |
詳細(xì)
|
| Kevetrin hydrochloride |
|
66592-89-0 |
詳細(xì)
|
| Histamine dihydrochloride |
組胺二鹽酸鹽 |
56-92-8 |
詳細(xì)
|
| Blu554 |
|
1707289-21-1 |
詳細(xì)
|
| Gaderic acid DM |
靈芝酸DM |
173075-45-1 |
詳細(xì)
|
| 740Y-P |
|
1236188-16-1 |
詳細(xì)
|
| EMA401 |
|
1316755-16-4 |
詳細(xì)
|
| Elagolix sodium |
噁拉戈利鈉 |
832720-36-2 |
詳細(xì)
|
| WP1015 |
|
857064-40-5 |
詳細(xì)
|
| KM 11060 |
|
774549-97-2 |
詳細(xì)
|
| 5-chloromethyl-2-methoxyphenyl 4-methylbenzenesulfonate |
|
1005494-35-8 |
詳細(xì)
|
| 4-Methyl-1-piperazinecarbonyl chloride hydrochloride |
4-甲基哌嗪-1-甲酰氯 鹽酸鹽 |
55112-42-0 |
詳細(xì)
|
| 1-Amino-3-methylurea |
1-氨基-3-甲基尿素 |
17696-95-6 |
詳細(xì)
|
| Tanzisertib |
|
899805-25-5 |
詳細(xì)
|
| D-xylo-Pentodialdo-5,2-furanose, 4,5-O-(1-Methylethylidene)-1-C-4-Morpholinyl-,(5S)- |
LX4211中間體 |
1103738-19-7 |
詳細(xì)
|
| GSK2330672 |
|
1345982-69-5 |
詳細(xì)
|
| Pembrolizumab |
派姆單抗 |
1374853-91-4 |
詳細(xì)
|
| 2-((4-methoxy-3-(tosyloxy)benzyl)sulfonyl)acetic acid |
|
1005494-37-0 |
詳細(xì)
|
| PF04418948 |
|
1078166-57-0 |
詳細(xì)
|
| LJI308 |
|
1627709-94-7 |
詳細(xì)
|
| CVT 313 |
|
199986-75-9 |
詳細(xì)
|
| Dimethoxycurcumin |
|
160096-59-3 |
詳細(xì)
|
| GR148672X |
|
263890-70-6 |
詳細(xì)
|
| ML241 |
|
1346528-06-0 |
詳細(xì)
|
| Puromycin aminonucleoside |
氨基核苷嘌呤霉素 |
58-60-6 |
詳細(xì)
|
| Ozenoxacin |
奧澤沙星 |
245765-41-7 |
詳細(xì)
|
| 2-(1-Trityl-1H-Imidazol-4-Yl)Benzaldehyde |
|
1402838-08-7 |
詳細(xì)
|
| MS023 |
|
1831110-54-3 |
詳細(xì)
|
| YM 90709 |
|
163769-88-8 |
詳細(xì)
|
| T-2 Toxin |
T-2毒素(鐮刀菌屬) |
21259-20-1 |
詳細(xì)
|
| 4-Amino-3-chlorophenylboronic acid, pinacol ester |
4-氨基-3-氯苯硼酸頻那醇酯 |
721960-43-6 |
詳細(xì)
|
| (S)-Alogliptin |
阿格列汀異構(gòu)體 |
1108732-05-3 |
詳細(xì)
|
| Lemborexant |
|
1369764-02-2 |
詳細(xì)
|
| PI3Kα inhibitor 1 |
|
1235449-52-1 |
詳細(xì)
|
| 5-phenoxyisobenzofuran-1,3-dione |
FG4592中間體;4-苯氧基鄰苯二甲酸酐 |
21345-01-7 |
詳細(xì)
|
| MK-571 sodiuM salt |
|
115103-85-0 |
詳細(xì)
|
| LY2334737 |
|
892128-60-8 |
詳細(xì)
|
| Methyl ((S)-1-((S)-2-(4-(4-broMophenyl)-1H-iMidazol-2-yl)pyrrolidin-1-yl)-3-Methyl-1-oxobutan-2-yl)carbaMate |
((S)-1-((S)-2-(4-(4-溴苯基)-1H-咪唑基)吡啶基)-3甲基-1-氧雜丁基氨基甲酸甲酯 |
1228552-27-9 |
詳細(xì)
|
| VX-759 sodium salt |
VCH-759（鈉鹽） |
1001913-13-8 |
詳細(xì)
|
| MK-8245 Trifluoroacetate |
|
1415559-41-9 |
詳細(xì)
|
| SM-164 |
|
957135-43-2 |
詳細(xì)
|
| Olodaterol hydrochloride |
鹽酸奧達(dá)特羅 |
869477-96-3 |
詳細(xì)
|
| Tas120 |
|
1448169-71-8 |
詳細(xì)
|
| Ivosidenib(racemic) |
|
1448346-63-1 |
詳細(xì)
|
| L685458 |
|
292632-98-5 |
詳細(xì)
|
| MRE-269 |
|
475085-57-5 |
詳細(xì)
|
| ACY-738 |
|
1375465-91-0 |
詳細(xì)
|
| (S)-H-1152 (hydrochloride) |
|
451462-58-1 |
詳細(xì)
|
| 5-Methyl-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)isoxazole |
5-甲基-1,2-異噁唑-4-硼酸嚬哪醇酯 |
1346808-41-0 |
詳細(xì)
|
| JZL195 |
|
1210004-12-8 |
詳細(xì)
|
| EGF816 |
|
1508250-71-2 |
詳細(xì)
|
| Olmutinib |
|
1802181-20-9 |
詳細(xì)
|
| PRE-084 hydrochloride |
|
75136-54-8 |
詳細(xì)
|
| GNF 7 |
|
839706-07-9 |
詳細(xì)
|
| VTX-2337 |
|
926927-61-9 |
詳細(xì)
|
| Ozanimod |
奧扎莫德 |
1306760-87-1 |
詳細(xì)
|
| GSK2879552 |
|
1401966-69-5 |
詳細(xì)
|
| LY2409881 trihydrochloride |
|
946518-60-1 |
詳細(xì)
|
| JH-II-127 |
|
1700693-08-8 |
詳細(xì)
|
| 2-Bromoisovanillin |
6-溴異香草醛 |
2973-59-3 |
詳細(xì)
|
| Meconin |
袂康寧 |
569-31-3 |
詳細(xì)
|
| FPS-ZM1 |
|
945714-67-0 |
詳細(xì)
|
| SGC-CBP30 |
|
1613695-14-9 |
詳細(xì)
|
| RBC8 |
|
361185-42-4 |
詳細(xì)
|
| UF 010 |
|
537672-41-6 |
詳細(xì)
|
| FMOC-THR(TBU)-OL |
N-[(1R,2R)-2-(1,1-二甲基乙氧基)-1-(羥基甲基)丙基]氨基甲酸 9H-芴-9-甲酯 |
189337-28-8 |
詳細(xì)
|
| AZD5597 |
|
924641-59-8 |
詳細(xì)
|
| WDR5 0103 |
|
890190-22-4 |
詳細(xì)
|
| N-(5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide |
GLPG-0634 中間體 |
1142943-96-1 |
詳細(xì)
|
| Lumateperone |
|
313368-91-1 |
詳細(xì)
|
| CPI-268456 |
|
1380087-86-4 |
詳細(xì)
|
| Atractyline |
蒼術(shù)酮 |
6989-21-5 |
詳細(xì)
|
| Finerenone |
非奈利酮 |
1050477-31-0 |
詳細(xì)
|
| Bempedoic acid |
貝派地酸 |
738606-46-7 |
詳細(xì)
|
| IDO-IN-1 |
|
914638-30-5 |
詳細(xì)
|
| 6-Thio-2'-Deoxyguanosine |
6-巰基-2'-脫氧鳥苷 |
789-61-7 |
詳細(xì)
|
| NIBR189 |
|
1599432-08-2 |
詳細(xì)
|
| Inotuzumab ozogamicin |
奧英妥珠單抗 |
635715-01-4 |
詳細(xì)
|
| 1-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine |
1-甲基-5-(4,4,5,5-四甲基-1,3,2-二氧雜環(huán)戊硼烷-2-基)-1H-吡咯并[2,3-B]吡啶 |
1220696-34-3 |
詳細(xì)
|
| AZD6738 |
|
1352226-88-0 |
詳細(xì)
|
| PS-1145 |
|
431898-65-6 |
詳細(xì)
|